Tri Capital Opportunities Corp. Grants Incentive Stock Options
VANCOUVER, British Columbia, June 05, 2020 (GLOBE NEWSWIRE) -- Tri Capital Opportunities Corp. (the "Company") (TSXV: TCAP.P) announces that the Company has issued an aggregate of 1,000,000 incentive stock options (the "Options") to officers and directors of the Company. The Options are exercisable at $0.10 per share for a period of ten years from the date of grant. The Options have been granted under and are governed by the terms of the Company's incentive stock option plan.
ON BEHALF OF THE BOARD
"James Gaydon Pettit" ________________________ James Gaydon Pettit CEO and President Contact Information
Tri Capital Opportunities Corp. Kelly Pladson, Corporate Secretary Email: [email protected] Telephone: (604) 639-3857
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...
